The FDA has approved Celltrion’s OMLYCLO (omalizumab-igec) as the first and only biosimilar designated as interchangeable ...

Nanomedicine holds immense promise for revolutionizing healthcare. By manipulating materials at the nanoscale, researchers ...

Amaran Biotechnology has signed a Memorandum of Understanding with Nippon Fine Chemical and its Taiwan subsidiary.

Limula has unveiled LimONE, a cell therapy manufacturing solution that automates complex and fragmented processes into a ...

Lonza Capsules & Health Ingredients has established a Center of Applied Sustainability. The Center will drive Lonza CHI’s ...

Adragos Pharma has completed a €4M project to install and commission a liquid filling line and accompanying cartoning machine ...

Astellas and Yaskawa are establishing a joint venture for the development of a cell therapy product manufacturing platform ...

This partnership aims to transform cell therapy workflows with Chain of Identity and Chain of Custody compliance standards.

ENCell’s investigational drug EN001 has been granted Orphan Drug Designation by the FDA for the treatment of ...

ProBioGen and Marea Therapeutics Inc. have successfully completed a sprint project to deliver clinical material for MAR002.

In an increasingly complex pharmaceutical landscape, companies face significant challenges in bringing their products from ...

Roche announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License ...